Related by context. Frequent words. (Click for all words.) 63 signal detection CTSD 61 Trial Issue www.emagazine.com 60 Phase Ib IIa 59 phase IIb clinical 58 Your FIFA.com 58 Initiates Phase II 57 phase IIa 57 remission induction 57 Phase Ib clinical 56 Completes Patient Enrollment 55 Phase Ia 55 Phase 1b clinical 55 HGS ETR2 55 blinded placebo controlled 55 diagnosed GBM 55 Meets Primary Endpoint 54 Daclizumab 54 Please respond insightfully 54 Initiate Phase 54 phase IIa clinical 54 diagnosed Ph + 54 huN# DM1 54 IIa trial 54 Phase IIa clinical trials 54 vosaroxin 54 Phase 2a clinical 53 Trace Christenson covers 53 Zoraxel 53 Allovectin 7 ® 53 Anthim 53 appropriate Impax 53 Pivotal Phase III 53 phase Ib 53 dose escalation clinical 53 multicenter Phase 53 Panzem R NCD 53 Phase Ib II 53 Phase IIa trials 53 Alagebrium 53 optical biosensors 52 By Bettingzone.co.uk Used 52 Phase IIa clinical 52 COMFORT II 52 mem. op 52 recurrent glioblastoma multiforme 52 Phase 1b trial 52 PSN# [002] 52 ReN# 52 confirmatory Phase III 52 Phase IIb trials 52 metastatic hormone refractory 52 diagnosed glioblastoma multiforme 52 Somaxon ability 52 Telintra 52 motesanib 52 histologically confirmed 52 thorough QT 52 Lovaxin C 51 Oncotype DX colon cancer 51 Reproductions must 51 KRN# 51 LibiGel Phase III 51 double blinded placebo 51 SUCCEED trial 51 Completes Enrollment 51 metastatic castration resistant 51 Romidepsin 51 ANG# 51 Allovectin 7 R 51 GRNVAC1 51 oral deforolimus 51 MIRCERA 51 Phase Ib clinical trials 51 Phase IIB 51 teriflunomide 51 relapsing multiple sclerosis 51 BioNeutral proprietary platform 50 GSK# [001] 50 Phase 2b clinical trials 50 olaparib 50 TOCOSOL Paclitaxel 50 ORMD 50 double blinded randomized 50 BrachySil 50 Aplidin 50 phase 2a 50 hormone refractory 50 SAR# [004] 50 multiple ascending dose 50 controlled multicenter 50 Cloretazine R VNP#M 50 tolerated dose MTD 50 PSMA ADC 50 secondary efficacy endpoint 50 preclinical efficacy 50 LCP Tacro 50 interferon gamma 1b 50 Phase 1a 50 ongoing Phase 1b 50 republished individually 50 randomized blinded